Abstract
This prospective study was designed to see the hypoglycemic properties of fenugreek seeds on the noninsulin-dependent diabetes mellitus patients. Fenugreek seed powder with a dose of 15mg/day was given to 34 noninsulin-dependent diabetes mellitus patients and 15 healthy controls for 30 days. The blood glucose (FBS and PPBS), Liver function test, lipid profile and Kidney function test were measured after 15 th , 30 th and 45 th day. We observed there was a significant reduction in FBS, PPBS and Hba1C levels after administration of Fenugreek seeds in diabetic patients. However no change was observed in liver functions, lipid profile and kidney functions which show fenugreek seeds have no toxicological effect. Fenugreek seed can be used as hypoglycemic agent in NIDDM patients. However close monitoring of vitals should always been done.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
